Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Limoneira is a farm products business based in the US. Limoneira shares (LMNR) are listed on the NASDAQ and all prices are listed in US Dollars. Limoneira employs 265 staff and has a trailing 12-month revenue of around $184.6 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $14.38 |
|---|---|
| 52-week range | $10.26 - $14.85 |
| 50-day moving average | $12.95 |
| 200-day moving average | $12.80 |
| Wall St. target price | $17.25 |
| PE ratio | N/A |
| Dividend yield | $0.3 (2.34%) |
| Earnings per share (TTM) | $-0.38 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $14.38 from 2023-02-01
| 1 week (2023-01-22) | N/A |
|---|---|
| 1 month (2022-12-29) | N/A |
| 3 months (2022-10-31) | 20.54% |
| 6 months (2022-08-02) | 12.61% |
| 1 year (2022-02-02) | -2.18% |
|---|---|
| 2 years (2021-02-02) | -8.41% |
| 3 years (2020-01-31) | 19.52 |
| 5 years (2018-02-02) | 20.82 |
Valuing Limoneira stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Limoneira's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Limoneira's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.8522. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Limoneira's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Limoneira's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.6 million.
The EBITDA is a measure of a Limoneira's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $184.6 million |
|---|---|
| Gross profit TTM | $19.5 million |
| Return on assets TTM | -0.38% |
| Return on equity TTM | -0.24% |
| Profit margin | -0.13% |
| Book value | $9.58 |
| Market capitalisation | $254.3 million |
TTM: trailing 12 months
We're not expecting Limoneira to pay a dividend over the next 12 months.
Limoneira's shares were split on a 10:1 basis on 7 April 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Limoneira shares – just the quantity. However, indirectly, the new 90% lower share price could have impacted the market appetite for Limoneira shares which in turn could have impacted Limoneira's share price.
Over the last 12 months, Limoneira's shares have ranged in value from as little as $10.261 up to $14.8522. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Limoneira's is 0.6379. This would suggest that Limoneira's shares are less volatile than average (for this exchange).
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates through three divisions: Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons. The company also grows avocado, oranges, and specialty citrus and other crops, including Moro blood oranges, Cara Cara oranges, Minneola tangelos, Star Ruby grapefruit, pummelos, pistachios, and wine grapes. It has approximately 5,600 acres of lemons planted primarily in Ventura, Tulare, San Luis Obispo, and San Bernardino Counties in California; and Jujuy, Argentina, as well in Yuma County, Arizona, and La Serena, Chile; 900 acres of avocados planted in Ventura County; 1,000 acres of oranges planted in Tulare County, California; and 1,000 acres of specialty citrus and other crops. In addition, the company rents residential housing units and commercial office buildings, as well as leases approximately 500 acres of its land to third-party agricultural tenants. Further, it is involved in the organic recycling operations; and development of land parcels, multi-family housing, and single-family homes.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.